Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Appendix B
Committee Meeting Agendas
Committee on Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response
First Committee Meeting Agenda
March 9, 2021 (7:00–10:00 a.m. EST)
March 10, 2021 (7:00–9:00 a.m. EST)
March 11, 2021 (7:00–9:00 a.m. EST)
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Tuesday, March 9, 2021
OPEN SESSION
| 8:25 a.m. | Welcome and Introductions PETER SANDS, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria |
| 8:30 a.m. | Speaker 1 and Discussion: The International Committee on Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response and Consensus Studies PRASHANT YADAV International Committee Cochair Senior Fellow Center for Global Development |
| 8:40 a.m. | Speaker 2 and Discussion: Sponsor Perspectives on the Charge to the Committee LARRY KERR Director, Pandemics and Emerging Threats Office of Global Affairs U.S. Department of Health and Human Services |
| 9:10 a.m. | Speaker 3 and Discussion: Envisioning Influenza at the World Health Organization: Global Frameworks and Partnerships for Influenza Vaccination SYLVIE BRIAND Director, Global Infectious Hazard Preparedness World Health Organization |
| 9:40 a.m. | Adjourn Open Session |
Wednesday, March 10, 2021
OPEN SESSION
| 7:00 a.m. | Welcome and Introductions PETER SANDS, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
| 7:05 a.m. | Speaker 1 and Discussion: Governance and Global Collaboration for Zoonotic Influenza and Vaccines IAN BROWN Steering Committee Chairman OIE/FAO Network of Expertise on Animal Influenza (OFFLU) |
| 7:30 a.m. | Speaker 2 and Discussion: Contemporary Perspectives on Pathogen Sharing: The Pandemic Influenza Preparedness (PIP) Framework and the Nagoya Protocol SANGEETA SHASHIKANT Legal Advisor Third World Network |
| 8:00 a.m. | Speaker 3 and Discussion: Global Partnerships for Influenza Vaccination JEREMY FARRAR Director Wellcome Trust |
| 8:30 a.m. | Speaker 4 and Discussion: The Global Supply of Influenza Vaccines: Governance, Progress, and Areas for Growth MARIE-PAULE KIENY Director of Research Institut National de la Santé et la Recherche Médicale (INSERM) |
| 8:55 a.m. | Closing Remarks and Adjourn Day 2 PETER SANDS, Committee Chair Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Second Committee Meeting Agenda
April 9, 2021 (8:00–11:00 a.m. EDT)
April 16, 2021 (7:00–10:00 a.m. EDT)
Friday, April 9, 2021
OPEN SESSION
| 8:55 a.m. | Welcome and Introductions |
| 9:00 a.m. | Speaker 1 and Discussion: Update on Global Manufacturing Capacity and Access Barriers for Influenza Vaccines THOMAS CUENI Chief Executive Officer, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) |
| 9:35 a.m. | Speaker 2 and Discussion: Potential Financing and Coordination Mechanisms for Pandemic Vaccination NICOLE LURIE Strategic Advisor to the Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI) |
| 10:10 a.m. | Closing Remarks |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Friday, April 16, 2021
OPEN SESSION
| 7:00 a.m. | Welcome and Introductions |
| 7:05 a.m. | Speaker 1: Governance Structures and Barriers in the African Region for Influenza Vaccine Manufacturing PATRICK TIPPOO Executive Committee Vice President, Developing Country Vaccine Manufacturing Network (DCVMN) Founding Member, African Vaccine Manufacturers Initiative (AVMI) Head of Science and Innovation, Biovac |
| 7:35 a.m. | Speaker 2: Current Challenges and Coordination Mechanisms in the MENA Region for Influenza Surveillance and Access SALAH AL AWAIDY Communicable Diseases Advisor, Ministry of Health, Oman |
| 8:00 a.m. | Speaker 3: The Developing Country Vaccine Manufacturers Network (DCVMN) and Current Challenges in Brazil for Influenza Vaccine Manufacturing TIAGO ROCCA Strategic Partnerships and Business Development Manager, Instituto Butantan Executive Committee Member, DCVMN |
| 8:30 a.m. | Closing Remarks |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Third Committee Meeting Agenda
May 6, 2021 (8:00–10:00 a.m. EDT): Three simultaneous working group sessions
May 7, 2021 (9:00–11:00 a.m. EDT): Three simultaneous working group sessions
May 11, 2021 (1:00–1:45 p.m. EDT): Single working group session
May 14, 2021 (8:00–11:00 a.m. EDT): Full committee session
Thursday, May 6, 2021
OPEN SESSION 1: TECHNOLOGY AND MANUFACTURING WORKING GROUP
| 8:25 a.m. | Welcome and Introductions BRUCE GELLIN Director, Global Immunization Sabin Vaccine Institute |
| 8:30 a.m. | Speaker 1: Public–Private Partnerships for Influenza Vaccine Development and Manufacturing and the Center for Infectious Disease Research and Policy’s (CIDRAP’s) Influenza Vaccine Research and Development Road Map JOSEPH BRESEE Associate Director, Global Health Affairs, Influenza Division Director, Partnership for Influenza Vaccine Introduction U.S. Centers for Disease Control and Prevention Director, Global Funders Consortium for Universal Influenza Vaccine Development |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
| 8:55 a.m. | Closing Remarks |
Friday, May 7, 2021
OPEN SESSION: PATHOGEN SHARING WORKING GROUP
| 9:30 a.m. | Welcome and Introductions ALEXANDRA PHELAN Assistant Professor Center for Global Health Science and Security Georgetown University |
| 9:35 a.m. | Speaker 1: Speed and Equity for Pathogen and Vaccine Sharing at the World Health Organization STEVEN SOLOMON Principal Legal Officer, World Health Organization |
| 10:00 a.m. | Speaker 2: Environmental Health Law, the Nagoya Protocol, and Influenza Pathogen Sharing JORGE E. VIÑUALES Harold Samuel Chair of Law and Environmental Policy Founder and Former Director, Cambridge Centre for Environment, Energy and Natural Resource Government, Cambridge University |
| 10:25 a.m. | Closing Remarks |
Friday, May 7, 2021
OPEN SESSION 2: TECHNOLOGY AND MANUFACTURING WORKING GROUP
| 9:00 a.m. | Welcome and Introductions BRUCE GELLIN Director, Global Immunization Sabin Vaccine Institute |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
| 9:05 a.m. | Speaker 1: The Coalition for Epidemic Preparedness and Innovations’ (CEPI’s) Role as a Broker and Facilitator of Manufacturing Partnerships JAMES ROBINSON CEPI Scientific Advisory Committee Vice Chair James Robinson Biologics Consulting |
| 9:30 a.m. | Closing Remarks |
Friday, May 7, 2021
OPEN SESSION: VACCINE ACCESS AND FINANCING WORKING GROUP
| 9:00 a.m. | Opening Remarks AMANDA GLASSMAN Senior Fellow and Executive Vice President Center for Global Engagement |
| 9:05 a.m. | Speaker 1: Lessons from Economic Theory: Developing Quick Pandemic Vaccines and Distributing Them Equitably GAVIN YAMEY Associate Director for Policy and Professor of the Practice of Global Health and Public Policy Director, Center for Policy Impact in Global Health Duke Global Health Institute |
| DAVID MCADAMS Professor of Business Administration, Fuqua School of Business Professor of Economics, Economics Department Duke University |
|
| OSONDU OGBUOJI Assistant Research Professor Deputy Director, Center for Policy Impact in Global Health Duke Global Health Institute |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
| 9:30 a.m. | Speaker 2: The World Bank’s Post-Pandemic Emergency Financing Facility Agenda for Financing Pandemic Preparedness and Economic Theory for Incentivizing Vaccine Access MUHAMMAD ALI PATE Global Director, Health, Nutrition and Population (HNP) Global Practice World Bank |
| 10:00 a.m. | Speaker 3: Europe’s Experiences with Procuring COVID-19 Vaccines ANDRZEJ RYS Director for Health Systems, Medical Products and Innovation Directorate-General for Health and Food Safety, European Commission |
| 10:20 a.m. | Closing Remarks |
Tuesday, May 11, 2021
OPEN SESSION 3: TECHNOLOGY AND MANUFACTURING WORKING GROUP
| 9:00 a.m. | Welcome and Introductions BRUCE GELLIN Director, Global Immunization Sabin Vaccine Institute |
| 1:00 p.m. | Speaker 1: Lessons Learned from the Global Action Plan for Influenza Vaccines’ (GAP’s) Technology Transfer Partnerships and the Biomedical Advanced Research and Development Authority’s (BARDA’s) International Influenza Vaccine Technology Manufacturing Capacity Program JULIE SCHAFER Chief Technology Officer Flu Lab |
| ERIN SPARROW Technical Officer World Health Organization |
|
| 1:45 p.m. | Closing Remarks |
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
This page intentionally left blank.
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
Suggested Citation:"Appendix B: Committee Meeting Agendas." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative. Washington, DC: The National Academies Press. doi: 10.17226/26284.
×
